David Bellovin,Kevin Baker,Thomas Brennan,Arundathy Nirmalini Pandite,Bijoyesh Mookerjee,Maurice P. DeYoung,Rakesh Kumar
申请号:
US14890047
公开号:
US09775881B2
申请日:
2014.05.22
申请国别(地区):
US
年份:
2017
代理人:
摘要:
Methods of treating cancers comprising administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or an FGFR1 ECD fusion molecule are provided. Methods of treating cancers comprising administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or an FGFR1 ECD fusion molecule and at least one anti-angiogenic agent are provided.